首页/数据集/Parameters used in the base case analysis for pneumococcal vaccination in Kenyan infants born in 2010 *BCV- Base case value.

Parameters used in the base case analysis for pneumococcal vaccination in Kenyan infants born in 2010 *BCV- Base case value.

NIAID Data Ecosystem2026-03-07 收录

肺炎球菌疫苗

婴儿免疫策略

数据链接：

https://figshare.com/articles/dataset/_Parameters_used_in_the_base_case_analysis_for_pneumococcal_vaccination_in_Kenyan_infants_born_in_2010_BCV_Base_case_value_/729491 数据链接链接失效反馈

官方服务：

资源简介：

NA- Not applicable.

应用场景：

创建时间：

2013-06-24

肺炎球菌疫苗

黏膜免疫机制

Host defenses against Streptococcus pneumoniae depend largely on opsonophagocytosis mediated by antibodies and complement. Since pneumococcus is a respiratory pathogen, mucosal immune responses may pl

PubMed Central50

Development of experimental pneumococcal vaccine for mucosal immunization

肺炎球菌疫苗

黏膜免疫

Streptococcus pneumonia is an important human pathogen that causes various severe diseases such as pneumonia, otitis and meningitis. Vaccination against S. pneumoniae is implemented in many developed

NIAID Data Ecosystem20

Practices towards pneumococcal vaccine (PCV) and reasons for not recommending it to patient groups among primary care doctors, Ukraine, 2021.

肺炎球菌疫苗

初级保健医生行为

Practices towards pneumococcal vaccine (PCV) and reasons for not recommending it to patient groups among primary care doctors, Ukraine, 2021.

NIAID Data Ecosystem10

The distribution of PCV aliquot given to children enrolled into the study, Ethiopia, 2011/2012.

儿童疫苗接种分布

肺炎球菌疫苗

The distribution of PCV aliquot given to children enrolled into the study, Ethiopia, 2011/2012.

NIAID Data Ecosystem50

Pneumococcal Vaccine Market Size, Share, Growth Analysis Report By Sector (Public and Private), By Vaccine Type (Pneumococcal Polysaccharide Vaccine and Pneumococcal Conjugate Vaccine), By Distribution Channel (Non-Government Organizations, Distribution Partner Companies, and Government Authorities), By Product Type (Pneumovax 23, Synflorix, and Prevnar 13), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030

肺炎球菌疫苗

市场分析

The global pneumococcal vaccination market was assessed at USD 8.57 billion in 2021 and is expected to exceed USD 12 billion by 2030 at a CAGR of 5.34%.

Parameters used in the base case analysis for pneumococcal vaccination in Kenyan infants born in 2010 *BCV- Base case value.

资源简介：

相关数据集